Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports.

MLA

Okiyama, N., et al. “Successful Topical Treatment with Ketoconazole for Facial Rashes Refractory to Dupilumab in Patients with Atopic Dermatitis: Case Reports.” Journal of the European Academy of Dermatology & Venereology, vol. 34, no. 9, Sept. 2020, pp. e474–76. EBSCOhost, https://doi.org/10.1111/jdv.16383.

APA

Okiyama, N., Nakamura, Y., Ishitsuka, Y., Inoue, S., Kubota, N., Saito, A., Watanabe, R., Fujisawa, Y., & Igawa, K. (2020). Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports. Journal of the European Academy of Dermatology & Venereology, 34(9), e474–e476. https://doi.org/10.1111/jdv.16383

Chicago

Okiyama, N., Y. Nakamura, Y. Ishitsuka, S. Inoue, N. Kubota, A. Saito, R. Watanabe, Y. Fujisawa, and K. Igawa. 2020. “Successful Topical Treatment with Ketoconazole for Facial Rashes Refractory to Dupilumab in Patients with Atopic Dermatitis: Case Reports.” Journal of the European Academy of Dermatology & Venereology 34 (9): e474–76. doi:10.1111/jdv.16383.